...a specialist pharmaceutical consultancy at the centre of a network of expert advisors and providers offering expert clinical, regulatory and commercial connectivity throughout the pharmaceutical and medical device industries
- trending_up
Strategic, regulatory, clinical, commercial and scientific direction to establish effective business partnerships across the globe.
Trinitas Services - share
We are specialists in product delivery with proven expertise in a wide range of product sectors across branded, generic, biotech, surgical and device technologies.
Specialist Sectors - group
An unrivalled network of contacts across the global pharma, medical device and CRO industries, including major R&D, commercial and regulatory functions at board level
Meet The Team
We Are Specialists
We are specialists in product delivery for the pharmaceutical industry, with proven experience in the following sectors:
- Branded
- Generics
- OTC
- Biotech
- Delivery systems and devices
- Surgical products - particularly those used in colorectal, pancreatic and gynaecological surgery
- Global and regional clinical trials
- Analytical materials for cell assays/genomic identification
Our Services
- Strategy and management
- Due diligence
- Business development and licensing
- Product identification and sourcing
- R&D Portfolio management
- Marketing intelligence
- Establishing and maintaining patents
- Design and conduct of clinical trials
- Project management
- Quality management systems and services
- Manufacturing and outsourcing - including IMPs
A Market Focused On Quality
Trinitas began by providing expertise and focus to approach the complex Japanese pharma and medical device markets. Having established product flow into to Japan for a number of clients, our portfolio of expertise has expanded to offer a full range of bespoke commercial and development services encompassing the global markets for both in- and out-licensing. Let Trinitas guide your programmes to the right commercial partner or help you seek your next in-licensing or acquisition candidate.